FDTD analysis of close-coupled 418 MHz radiating devices for human biotelemetry

Theory and applications of biotelemetry

In this study, biotelemetry and its evolution is explained in detail. Bioelectric and physiological variables could be measured by biotelemetry systems. The development of a biotelemetry system and its principal operation are presented. The components of a biotelemetry system are explained. Biomedical data has been telemetered through every medium between two sites by using a variety of modulated energy forms. Designing of the link between transmitter and receiver is described. Important factors in designing a backpack or implanted telemeter are explained. The main features of implanted biotelemetry units are determined. Single-channel and multichannel biotelemetry systems are defined. The types of telemetry, and a comparison thereof, are given. The power sources of biotelemetry systems and features of different power sources are explained. A survey of biotelemetry applications on humans and animals is presented and advantages of using biotelemetry systems are determined.

Hyperthermia treatment planning

The development of hyperthermia, the treatment of tumours with elevated temperatures in the range of 40-44 degrees C with treatment times over 30 min, greatly benefits from the development of hyperthermia treatment planning. This review briefly describes the state of the art in hyperthermia technology, followed by an overview of the developments in hyperthermia treatment planning. It particularly highlights the significant problems encountered with heating realistic tissue volumes and shows how treatment planning can help in designing better heating technology. Hyperthermia treatment planning will ultimately provide information about the actual temperature distributions obtained and thus the tumour control probabilities to be expected. This will improve our understanding of the present clinical results of thermoradiotherapy and thermochemotherapy, and will greatly help both in optimizing clinical heating technology and in designing optimal clinical trials.

Radiowave propagation from a tissue-implanted source at 418 MHz and 916.5 MHz

Tissue-implanted ultra-high frequency (UHF) radio devices are being employed in both humans and animals for telemetry and telecommand applications. This paper describes the experimental measurement and electromagnetic modeling of propagation from 418-MHz and 916.5-MHz sources placed in the human vagina. Whole-body homogeneous and semi-segmented software models were constructed using data from the Visible Human Project. Bodyworn radiation efficiencies for a vaginally placed 418-MHz source were calculated using finite-difference time-domain and ranged between 1.6% and 3.4% (corresponding to net body losses of between 14.7 and 18.0 dB). Greater losses were encountered at 916.5 MHz, with efficiencies between 0.36% and 0.46% (net body loss ranging between 23.4 and 24.4 dB). Practical measurements were in good agreement with simulations, to within 2 dB at 418 MHz and 3 dB at 916.5 MHz. The degree of tissue-segmentation for whole-body models was found to have a minimal effect on calculated azimuthal radiation patterns and bodyworn radiation efficiency, provided the region surrounding the implanted source was sufficiently detailed.